Yoshikawa S., Yoshikawa S., Sato A., Matsumoto T. Poor removal of tedizolid during continuous hemodiafiltration: experiments using an in vitro continuous hemodiafiltration model, Journal of Pharmaceutical Health Care and Sciences, 9(1), 37, https://doi.org/10.1186/s40780-023-00307-9, 2023.
Yoshikawa S., Komori R., Suzuki Y., Hanabusa Y., Kusano G., Sato A., Yoshikawa S., Matsumoto T. Hypoalbuminemia, a significant risk factor for thrombocytopenia associated with tedizolid therapy, Journal of Drug Interaction Research, 47, 73-79, 2023.
Yoshikawa S., Yoshikawa S., Sato A., Kusano G., Matsumoto T. Suitability of 5% glucose solution and Solita®-T No. 3 for infusion of tedizolid phosphate, Journal of Drug Interaction Research 45, 129-133 (2021)